Similar articles

• Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

  Banks E, Canfell K. Banks E, et al. Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25. Am J Epidemiol. 2009. PMID: 19468078
• Myocardial infarction and coronary atherosclerosis in Finland. An autopsy study covering 12 months in 1964-1965.

  Möttönen M. Möttönen M. Acta Pathol Microbiol Scand Suppl. 1969;205:1-89. Acta Pathol Microbiol Scand Suppl. 1969. PMID: 5265823 No abstract available.
• [Coronary heart disease in women].

  Kaaja R, Leinonen P. Kaaja R, et al. Duodecim. 1997;113(15):1447-58. Duodecim. 1997. PMID: 10643118 Review. Finnish. No abstract available.
• Coronary heart disease in women: 1996.

  Wenger NK. Wenger NK. Semin Reprod Endocrinol. 1996 Feb;14(1):5-14. doi: 10.1055/s-2007-1016304. Semin Reprod Endocrinol. 1996. PMID: 8796922 Review. No abstract available.
• Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.

  Mohandas B, Mehta JL. Mohandas B, et al. Curr Opin Cardiol. 2007 Sep;22(5):434-42. doi: 10.1097/HCO.0b013e328201cb7a. Curr Opin Cardiol. 2007. PMID: 17762545